Answer
Intravenous fosfomycin should be prescribed during pregnancy only when the benefit outweighs the risk, because no data exist on intravenous use in pregnant women and fosfomycin crosses the placenta, although animal studies do not indicate reproductive toxicity.
Sources for this answer
- Fomicyt 40 mg/ml powder for solution for infusionInfectoPharm Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked